Ultrasound in Medicine and Biology
Volume 35, Issue 9 , Pages 1458-1467 , September 2009

Quantitative Analysis of the Magnitude and Time Delay of Cyclic Variation of Myocardial Backscatter from Asymptomatic Type 2 Diabetes Mellitus Subjects

Received 5 December 2008 ,Revised 6 February 2009 ,Accepted 10 April 2009.

References 

  1. Akdemir O, Dagdeviren B, Altun A, Ugur B, Arikan E, Tugrul A, et al. Quantitative ultrasonic myocardial texture analysis of the diabetic heart. Anadolu Kardiyol Derg. 2001;1:17–21AXIII
  2. Alavaikko M, Elfving R, Hirvonen J, Jarvi J. Triglycerides, cholesterol, and phospholipids in normal heart papillary muscle and in patients suffering from diabetes, cholelithiasis, hypertension, and coronary atheroma. J Clin Pathol. 1973;26:285–293
  3. Augustus AS, Kako Y, Yagyu H, Goldberg IJ. Routes of fa delivery to cardiac muscle: Modulation of lipoprotein lipolysis alters uptake of tg-derived fa. Am J Physiol Endocrinol Metab. 2003;284:E331–E339
  4. Bamber D. The area above the ordinal dominance graph and the area below the receiver operating characteristic graph. J Math Psych. 1975;12:387–415
  5. Barrett-Connor E, Grundy SM, Holdbrook MJ. Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol. 1982;115:657–663
  6. Barzilai B, Madaras EI, Sobel BE, Miller JG, Perez JE. Effects of myocardial contraction on ultrasonic backscatter before and after ischemia. Am J Physiol. 1984;247:H478–H483
  7. Borradaile NM, Schaffer JE. Lipotoxicity in the heart. Curr Hypertens Rep. 2005;7:412–417
  8. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta. 2005;1734:112–126
  9. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest. 2001;107:813–822
  10. Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res. 2005;96:225–233
  11. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics. 1988;44:837–845
  12. Di Bello V, Talarico L, Picano E, Di Muro C, Landini L, Paterni M, et al. Increased echodensity of myocardial wall in the diabetic heart: An ultrasound tissue characterization study. J Am Coll Cardiol. 1995;25:1408–1415
  13. Di Bello V, Giampietro O, Matteucci E, Talarico L, Giorgi D, Bertini A, et al. Ultrasonic videodensitometric analysis in type 1 diabetic myocardium. Coron Artery Dis. 1996;7:895–901
  14. Di Bello V, Giampietro O, Matteucci E, Giorgi D, Bertini A, Piazza F, et al. Ultrasonic tissue characterization analysis in type 1 diabetes: A very early index of diabetic cardiomyopathy?. G Ital Cardiol. 1998;28:1128–1137
  15. Di Bello V, Santini F, Di Cori A, Pucci A, Palagi C, Delle Donne MG, et al. Obesity cardiomyopathy: Is it a reality? An ultrasonic tissue characterization study. J Am Soc Echocardiogr. 2006;19:1063–1071
  16. Efron B. The jackknife, the bootstrap and other resampling plans. CBMS-NSF Regional Conference Series in Applied Mathematics, Philadelphia, 1982.
  17. Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol. 2003;41:611–617
  18. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004;25:543–567
  19. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, et al. A critical role for pparalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content. Proc Natl Acad Sci U S A. 2003;100:1226–1231
  20. Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: Evidence for insulin resistance. J Clin Endocrinol Metab. 1985;61:807–811
  21. Fukunaga K. Introduction to statistical pattern recognition. Orlando, FL: Academic Press; 1972;50–59
  22. Gallas BD. One-shot estimate of mrmc variance: AUC. Acad Radiol. 2006;13:353–362
  23. Giglio V, Pasceri V, Messano L, Mangiola F, Pasquini L, Dello Russo A, et al. Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy. J Am Coll Cardiol. 2003;42:309–316
  24. Hallgren B, Stenhagen S, Svanborg A, Svennerholm L. Gas chromatographic analysis of the fatty acid composition of the plasma lipids in normal and diabetic subjects. J Clin Invest. 1960;39:1424–1434
  25. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA. 1974;229:1749–1754
  26. Hancock JE, Cooke JC, Chin DT, Monaghan MJ. Determination of successful reperfusion after thrombolysis for acute myocardial infarction: A noninvasive method using ultrasonic tissue characterization that can be applied clinically. Circulation. 2002;105:157–161
  27. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (roc) curve. Radiology. 1982;143:29–36
  28. Holland MR, Gibson AA, Peterson LR, Areces M, Schaffer JE, Perez JE, et al. Measurements of the cyclic variation of myocardial backscatter from two-dimensional echocardiographic images as an approach for characterizing diabetic cardiomyopathy. J Cardiometab Syndr. 2006;1:149–152
  29. Holland MR, Gibson AA, Kirschner CA, Hicks D, Ludomirsky A, Singh GK. Intrinsic myoarchitectural differences between the left and right ventricles of fetal human hearts: An ultrasonic backscatter feasibility study. J Am Soc Echocardiogr. 2009;In press
  30. Hu X, Wang J, Sun Y, Jiang X, Sun B, Fu H, et al. Relation of ultrasonic tissue characterization with integrated backscatter to contractile reserve in patients with chronic coronary artery disease. Clin Cardiol. 2003;26:485–488
  31. Iwakura K, Ito H, Kawano S, Okamura A, Asano K, Kuroda T, et al. Detection of timi-3 flow before mechanical reperfusion with ultrasonic tissue characterization in patients with anterior wall acute myocardial infarction. Circulation. 2003;107:3159–3164
  32. Joint National Committee on the Prevention D, Evaluation, and Treatment of High Blood Pressure. The seventh report of the joint national committee on the prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206
  33. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol. 1974;34:29–34
  34. Kannel WB, Vasan RS, Keyes MJ, Sullivan LM, Robins SJ. Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham offspring cohort). Am J Cardiol. 2008;101:497–501
  35. Komuro K, Yamada S, Mikami T, Yoshinaga K, Noriyasu K, Goto K, et al. Sensitive detection of myocardial viability in chronic coronary artery disease by ultrasonic integrated backscatter analysis. J Am Soc Echocardiogr. 2005;18:26–31
  36. Losi MA, Betocchi S, Chinali M, Barbati G, D'Alessandro G, Cacace A, et al. Myocardial texture in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2007;20:1253–1259
  37. Madaras EI, Barzilai B, Perez JE, Sobel BE, Miller JG. Changes in myocardial backscatter throughout the cardiac cycle. Ultrason Imaging. 1983;5:229–239
  38. Mann H, Whitney D. On a test whether one of two random variables is stochastically larger than the other. Ann Math Statist. 1947;18:50–60
  39. Masuyama T, St Goar FG, Tye TL, Oppenheim G, Schnittger I, Popp RL. Ultrasonic tissue characterization of human hypertrophied hearts in vivo with cardiac cycle-dependent variation in integrated backscatter. Circulation. 1989;80:925–934
  40. Micari A, Pascotto M, Jayaweera AR, Sklenar J, Goodman NC, Kaul S. Cyclic variation in ultrasonic myocardial integrated backscatter is due to phasic changes in the number of patent myocardial microvessels. J Ultrasound Med. 2006;25:1009–1019
  41. Mobley J, Banta CE, Gussak HM, Perez JE, Miller JG. Clinical tissue characterization: Online determination of magnitude and time delay of myocardial backscatter. Video J Echocardiogr. 1995;5:40–48
  42. Mohr GA, Vered Z, Barzilai B, Perez JE, Sobel BE, Miller JG. Automated determination of the magnitude and time delay (“Phase”) of the cardiac cycle dependent variation of myocardial ultrasonic integrated backscatter. Ultrason Imaging. 1989;11:245–259
  43. Naito J, Masuyama T, Mano T, Yamamoto K, Doi Y, Kondo H, et al. Influence of preload, afterload, and contractility on myocardial ultrasonic tissue characterization with integrated backscatter. Ultrasound Med Biol. 1996;22:305–312
  44. Nielsen LB, Bartels ED, Bollano E. Overexpression of apolipoprotein b in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem. 2002;277:27014–27020
  45. Ohara Y, Hiasa Y, Hosokawa S, Suzuki N, Takahashi T, Kishi K, et al. Ultrasonic tissue characterization predicts left ventricular remodeling in patients with acute anterior myocardial infarction after primary coronary angioplasty. J Am Soc Echocardiogr. 2005;18:638–643
  46. Perez JE, McGill JB, Santiago JV, Schechtman KB, Waggoner AD, Miller JG, et al. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol. 1992;19:1154–1162
  47. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004;109:2191–2196
  48. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 2008;52:1793–1799
  49. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 2004;18:1692–1700
  50. Stremmel W. Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport process. J Clin Invest. 1988;81:844–852
  51. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, et al. Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med. 2003;49:417–423
  52. Wagner RF, Wear KA, Perez JE, McGill JB, Schechtman KB, Miller JG. Quantitative assessment of myocardial ultrasound tissue characterization through receiver operating characteristic analysis of bayesian classifiers. J Am Coll Cardiol. 1995;25:1706–1711
  53. Wallace TM, Levy JC, Matthews DR. Use and abuse of homa modeling. Diabetes Care. 2004;27:1487–1495
  54. Wilcoxon F. Individual comparisons by ranking methods. Biometrics. 1945;1:80–83
  55. Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 2008;51:93–102
  56. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004;110:3081–3087
  57. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, et al. Lipotoxic heart disease in obese rats: Implications for human obesity. Proc Natl Acad Sci U S A. 2000;97:1784–1789

PII: S0301-5629(09)00156-2

doi: 10.1016/j.ultrasmedbio.2009.04.003

Ultrasound in Medicine and Biology
Volume 35, Issue 9 , Pages 1458-1467 , September 2009

Article Tools

* Image Usage & Resolution